News Releases

News & Resources

News Releases

Synteract Senior Director Kristi Clark to Present on Effective Communication Plans for Vendor Management at Outsourcing in Clinical Trials New England Conference

Synteract Silver Sponsor at 3rd Annual Biotech-Pharma Conference


SAN DIEGO – Sept. 14, 2011 – Kristi Clark, senior director of global initiatives at Synteract, Inc., is slated to speak on Establishing Effective Communication Plans to Master Multiple Vendor Management at the 3rd Annual Outsourcing in Clinical Trials Conference to be held in Boston, Sept 28-29, 2011. Clark will present at 4 p.m. EST, Wed., Sept. 28, on a variety of pertinent communication topics relating to global clinical studies. Synteract will exhibit and participate as a sponsor at the conference. 


Specific areas of discussion will include identification of concepts that help businesses to define processes among all participants to harmonize trial procedures and work toward a common goal. Clark encourages any executives that utilize several vendors and work on clinical studies in remote places to attend the presentation. She will also discuss generating a fail-safe work instruction for functional cross-vendor documentation in preparation of an FDA inspection. 

“Running successful global studies requires thorough upfront planning on the part of the lead CRO,” explains Clark. “Establishing a sound communication plan, harmonizing SOPs across all vendors, clearly defining roles and responsibilities, and ensuring that all vendors function as one team are essential in attaining this goal.” 

With more than 20 years of industry experience, which includes 14 years of global trial experience in the biopharma industry, Clark’s background has spanned the full scope of studies, from start-up to project closeout, including successfully running studies with multiple CRO vendors. She was tasked with expanding Synteract’s global footprint and opened Synteract’s first international office in Prague, Czech Republic. 

Stewart Bieler, Synteract’s chief operating officer, complimented Clark’s achievements and highlighted the importance of effective communication strategies for pharma, biotech, and medical device companies. 

“Kristi is well-versed in global communication strategies and vendor management, an integral topic for CROs, pharma, and biotech companies. With her help, Synteract has streamlined our processes to enhance success and eliminate unnecessary duplication.” 

Synteract, Inc., is a silver sponsor at the 3rd Annual Outsourcing in Clinical Trials Conference. Synteract executives will be at booth 34 for both days of the conference and available to answer any questions. To schedule a meeting, contact beth@clearpointagency.com 


About Synteract 
Synteract is a privately-held, full-service contract research organization, serving clinical trial needs of biotechnology, medical device, and pharmaceutical companies. Synteract provides high quality, customized service, working closely with drug and device sponsors. Headquartered in California, with offices in North Carolina and Czech Republic, Synteract offers clinical expertise in multiple therapeutic areas, including a strong emphasis in oncology, central nervous system (CNS), cardiovascular, respiratory, and ophthalmology. Information: http://www.synteract.com; (760) 268.8200. 

CONTACT: 
Beth Walsh 
Clearpoint Agency, for Synteract 
beth@clearpointagency.com 
858-724-2500

x

Contact Synteract

Tell us how to stay in touch with you:

*Required